|
|
|
|
|
Session 101
Poster Abstracts Antiretroviral Therapy: Regimens, Predictors of Response, and Clinical Outcomes Thursday, 1:30 - 3:30 pm Hall A |
Background: Gender differences in morbidity and mortality
have been reported and mainly attributed to poor care and research access. This
study evaluated these differences between HIV+ men and women with
equitable access to HAART and health care.
Methods: Using a longitudinal design, gender
differences in utilization of health services and HAART that may affect HIV
immune status, morbidity, and mortality were investigated. A total of 539 HIV+
subjects (307 men and 232 women) consecutively admitted to
Results: Fewer than half of the participants were
receiving HAART. Although no statistical gender differences were evident in
demographics, HAART, viral load, or CD4 counts, univariate
analyses revealed gender differences in rate of hospitalization (1.9/100 men-years vs
3.9/100 women-years). Women were twice as likely to be
hospitalized > 3 times during the length of the study than men (p = 0.003) and more likely to be
admitted with genitourinary infections (2 times, p = 0.003). Men were more likely to present with renal
insufficiency (OR = 1.68, p = 0.05) or
with malignancies (11% men vs 2.1% women, p = 0.0008). After controlling for HAART
and CD4, regression analysis showed that cancer and renal insufficiency were
significantly associated with mortality. A higher number of emergency
admissions were also evident among women (11.4 ± 0.8 vs
19.5 ± 1.2; p = 0.0001).
Interestingly, no gender differences in out-patient follow-up (46 ± 3.8 vs 50 ± 4.3) were apparent. Overall mortality during the
study period was 7.9% (n = 43) with 70% of the deaths occurring among men. Neither alcohol, drug use, nor HAART accounted for these
differences. When data were analyzed in patients 50 years and older, the
variables that were substantially different between genders failed to remain significant.
Conclusions:
Despite similar access to health care
and HAART, hospitalization and emergency visits are more prevalent among HIV+
women. Death rate, on the contrary, is higher among HIV+ men, and is
associated with an increased proportion of malignancies and renal insufficiency.
The effect of aging factors, such as hormonal fluctuation, may be related to
these gender differences and warrants further study.
Keywords: Gender; Hospitalization; Mortality
![]() |